The 2024 Irish Open will be sponsored by Amgen after a new name for announced for the DP World Tour tournament.

The Amgen takes over from Horizon, who have sponsored the prestigious tournament since 2022, with the renaming coming following the acquisition of Horizon Therapeutics plc in October 2023.

Horizon had agreed a multi-year commitment when first taking on the sponsorship.

The 2024 Amgen Irish Open, part of the DP World Tour, will take place at the Royal County Down Golf Club (pictured in main image) in Northern Ireland from September 11-15, 2024.

“Sponsorship of the Amgen Irish Open marks an important milestone in Amgen’s 25-year history in Ireland, and today’s announcement further demonstrates our commitment to the communities where our people live and work,” said Robert A. Bradway, chairman and chief executive officer at Amgen.

“We are especially pleased to sponsor the Amgen Irish Open, recognizing that the tournament contributes significantly to the Irish economy, and is a source of national pride.”

Irish professional golfers Shane Lowry, Padraig Harrington, Seamus Power and Brendan Lawlor served as golf ambassadors on behalf of Horizon Therapeutics, and they will now become Amgen golf ambassadors, wearing the Amgen logo while in competition.

Amgen will also become a partner to the KPMG Women’s Irish Open.

What is Amgen?

Amgen established a commercial presence in Ireland in 1998, and in 2011 it acquired a manufacturing facility in Dun Laoghaire, which it has since developed and upgraded with $1 billion in additional investment.

Today Amgen employs approximately 1,250 people in Ireland. Irish patient organizations supported by Amgen include the Irish Osteoporosis Society, Multiple Myeloma Ireland and CROÍ, a charity to prevent heart disease and stroke.

Award-winning biology education programs sponsored by the Amgen Foundation have reached 500 science teachers and nearly 60,000 students across Ireland.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.